SB202190 

To Order Contact us: stephen@expresspharmapulse.com

SB202190 (FHPI)

A1632-5.1 10 mM (in 1mL DMSO)
EUR 113
Description: SB202190 (FHPI) is a potent p38 MAPK inhibitor that specifically inhibits p38? and p38? with IC50 values of 50 and 100 nM, respectively [1].SB202190 has been reported to potently enhance the growth of leukemia cell lines THP-1 and MV4-11.

SB202190 (p38 MAP kinase inhibitor)

SIH-473-25MG 25 mg
EUR 429
  • SB202190 is a highly selective and potent inhibitor of p38 MAP kinase. Specifically, it binds within the ATP pocket of the active kinase and selectively inhibits the p38? and ? isoforms. It has been shown to induce apoptosis. SB202190 is cell-permeab
  • Show more
Description: The substance SB202190 is a p38 map kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is pale yellow solid which is soluble in methanol, DMSO or acetone; slightly soluble in ethyl acetate.

SB202190 (p38 MAP kinase inhibitor)

SIH-473-5MG 5 mg
EUR 160
  • SB202190 is a highly selective and potent inhibitor of p38 MAP kinase. Specifically, it binds within the ATP pocket of the active kinase and selectively inhibits the p38? and ? isoforms. It has been shown to induce apoptosis. SB202190 is cell-permeab
  • Show more
Description: The substance SB202190 is a p38 map kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is pale yellow solid which is soluble in methanol, DMSO or acetone; slightly soluble in ethyl acetate.

SB202190